Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.2%

1 terminated/withdrawn out of 24 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

25%

6 trials in Phase 3/4

Results Transparency

12%

2 of 17 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A

8(42.1%)

Phase 2

5(26.3%)

Phase 3

3(15.8%)

Phase 4

3(15.8%)

19Total

N/A(8)

Phase 2(5)

Phase 3(3)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials

NCT06737406Not ApplicableRecruiting

Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart

Role: lead

NCT05969730Not ApplicableCompleted

Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis

Role: lead

NCT07210450Phase 2Completed

Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia

Role: lead

NCT07120841Not ApplicableCompleted

Nurse Telephone Follow-up for Cardiovascular Patients

Role: lead

NCT04979650Phase 2Completed

Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis

Role: lead

NCT06653348Phase 2Recruiting

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Role: lead

NCT06812000Completed

Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy

Role: lead

NCT06608784Completed

Comparison Study of Electrocardiogram Indexes in Patients With Epilepsy, Patients With First Seizure and Normal Population

Role: lead

NCT06393309Completed

Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

Role: lead

NCT04738097Phase 3Completed

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

Role: lead

NCT04273516Phase 2Completed

Rivaroxaban Plus ASA in Embolic Stroke of Undetermined Source(AREST-ESUS)

Role: lead

NCT01766128Phase 2Withdrawn

Study of Zonisamide in Early Parkinson Disease

Role: lead

NCT05008354Phase 4Completed

Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam

Role: collaborator

NCT03940326Phase 4Completed

Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures

Role: lead

NCT05160350Phase 4Completed

Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy

Role: lead

NCT04763070Not ApplicableCompleted

Ciprofloxacin in Drug-resistant Epilepsy

Role: lead

NCT02535611Phase 3Completed

Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome

Role: lead

NCT04283747Unknown

Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis

Role: lead

NCT04309357Completed

Thrombolysis Outcome in Ischemic Stroke

Role: lead

NCT04327349Not ApplicableUnknown

Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial

Role: lead